ATE269104T1 - Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert - Google Patents

Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert

Info

Publication number
ATE269104T1
ATE269104T1 AT00204630T AT00204630T ATE269104T1 AT E269104 T1 ATE269104 T1 AT E269104T1 AT 00204630 T AT00204630 T AT 00204630T AT 00204630 T AT00204630 T AT 00204630T AT E269104 T1 ATE269104 T1 AT E269104T1
Authority
AT
Austria
Prior art keywords
flagella
flagellin
induce antibodies
salmonella vaccine
relates
Prior art date
Application number
AT00204630T
Other languages
German (de)
English (en)
Inventor
Petrus Johannes Maria Nuijten
Maarten Hendrik Witvliet
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE269104T1 publication Critical patent/ATE269104T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00204630T 1999-12-28 2000-12-19 Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert ATE269104T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204564 1999-12-28

Publications (1)

Publication Number Publication Date
ATE269104T1 true ATE269104T1 (de) 2004-07-15

Family

ID=8241112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00204630T ATE269104T1 (de) 1999-12-28 2000-12-19 Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert

Country Status (15)

Country Link
US (2) US20010021386A1 (cg-RX-API-DMAC7.html)
EP (1) EP1112747B1 (cg-RX-API-DMAC7.html)
JP (1) JP5745731B2 (cg-RX-API-DMAC7.html)
AT (1) ATE269104T1 (cg-RX-API-DMAC7.html)
AU (1) AU783508B2 (cg-RX-API-DMAC7.html)
BR (1) BR0006291B1 (cg-RX-API-DMAC7.html)
CA (1) CA2329676A1 (cg-RX-API-DMAC7.html)
DE (1) DE60011560T2 (cg-RX-API-DMAC7.html)
DK (1) DK1112747T3 (cg-RX-API-DMAC7.html)
ES (1) ES2222152T3 (cg-RX-API-DMAC7.html)
HU (1) HU226192B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA00012796A (cg-RX-API-DMAC7.html)
PL (1) PL206377B1 (cg-RX-API-DMAC7.html)
PT (1) PT1112747E (cg-RX-API-DMAC7.html)
TR (1) TR200401569T4 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4751570B2 (ja) * 2002-09-11 2011-08-17 東レ・ダウコーニング株式会社 オルガノポリシロキサン変性多糖類およびその製造方法
PL2066339T3 (pl) 2006-09-18 2015-02-27 Univ Arkansas Kompozycje i sposoby zwiększania odpowiedzi immunologicznych
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
CA2704457A1 (en) * 2007-10-30 2009-05-07 Walter Bottje Compositions and methods of enhancing immune responses to flagellated bacterium
AU2008318357B2 (en) 2007-11-01 2015-01-22 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria
WO2009062112A2 (en) 2007-11-09 2009-05-14 The Salk Institute For Biological Studies Use of tam receptor inhibitors as antimicrobials
DK2525817T3 (en) 2010-01-21 2017-10-02 Univ Arkansas Vaccine vectors and methods for enhancing immune responses
NZ718006A (en) 2010-06-09 2017-06-30 Univ Arkansas Vaccine and methods to reduce campylobacter infection
KR101449417B1 (ko) 2012-06-20 2014-10-27 한국외국어대학교 연구산학협력단 살모넬라 엔테리카의 박테리오파아지 및 그 용도
RU2683027C2 (ru) 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
CA2900644C (en) 2013-02-14 2023-03-14 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
WO2014164607A1 (en) 2013-03-11 2014-10-09 The Brigham And Women's Hospital, Inc. Vibro-based delivery system and immune suppression
AU2014239557B2 (en) 2013-03-15 2019-01-03 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
TWI843057B (zh) 2016-05-03 2024-05-21 阿肯色州大學董事會 包含免疫刺激性及抗原性多肽的酵母菌疫苗載體以及其使用方法
CN111374094B (zh) * 2020-03-02 2022-04-19 扬州大学 驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法
CN118773056B (zh) * 2024-07-10 2025-07-08 山东省滨州畜牧兽医研究院 一种马流产沙门氏菌灭活疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1109179A (en) * 1964-09-30 1968-04-10 Nat Res Dev Improvements relating to typhoid and paratyphoid vaccines
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.
DE68922394T2 (de) * 1988-05-05 1995-10-05 Praxis Biolog Inc Rekombinante vakzine von flagellin.
US6130082A (en) * 1988-05-05 2000-10-10 American Cyanamid Company Recombinant flagellin vaccines
JP3436756B2 (ja) * 1988-12-19 2003-08-18 アメリカン・サイアナミド・カンパニー 髄膜炎菌のクラスｉの外膜タンパク質のワクチン
DE69528450T2 (de) * 1994-02-18 2003-01-23 Solidose, L.L.C. Impfung von tieren mit getrockneten pelletierten biologischen materialien
GB9621091D0 (en) * 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6190669B1 (en) * 1998-05-13 2001-02-20 University Of Maryland, Baltimore Attenuated mutants of salmonella which constitutively express the Vi antigen

Also Published As

Publication number Publication date
DK1112747T3 (da) 2004-10-25
MXPA00012796A (es) 2002-05-23
PT1112747E (pt) 2004-10-29
EP1112747B1 (en) 2004-06-16
DE60011560D1 (de) 2004-07-22
BR0006291B1 (pt) 2014-02-18
DE60011560T2 (de) 2005-08-18
PL206377B1 (pl) 2010-08-31
US20080069843A1 (en) 2008-03-20
AU783508B2 (en) 2005-11-03
ES2222152T3 (es) 2005-02-01
JP2001186874A (ja) 2001-07-10
BR0006291A (pt) 2001-11-27
HUP0005010A2 (en) 2002-06-29
EP1112747A1 (en) 2001-07-04
PL344851A1 (en) 2001-07-02
JP5745731B2 (ja) 2015-07-08
TR200401569T4 (tr) 2004-07-21
HU226192B1 (en) 2008-06-30
US20010021386A1 (en) 2001-09-13
AU7245300A (en) 2001-07-05
HU0005010D0 (cg-RX-API-DMAC7.html) 2001-02-28
HUP0005010A3 (en) 2004-07-28
CA2329676A1 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
ATE269104T1 (de) Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert
EP1499191A4 (en) REGULATED ATTENUATION OF LIVE VACCINES TO ENHANCE CROSS-PROTECTIVE IMMUNOGENICITY
CY1119376T1 (el) Αντισωματα ειδικα για τη μορφη πρωτοϊνιδιου της βητα-αμυλοειδους πρωτεϊνης
DK1534335T3 (da) FcgammaRIIB-specifikke antistoffer og fremgangsmåder til anvendelse deraf
MX393384B (es) Adyuvantes sinteticos de glucopiranosil-lipido.
WO2004060308A3 (en) Thiosemicarbazones as anti-virals and immunopotentiators
CY1106467T1 (el) Ελεγχομενη συνθεση ζιπρασιδονης
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
ATE263157T1 (de) Nematizide trifluorbutene
CY1110537T1 (el) Ενωσεις και μεθοδοι για την αγωγη της δυσλιπιδαιμιας
EP1594560A4 (en) COMPOSITIONS, METHODS AND KITS FOR INCREASING THE IMMUNOGENICITY OF A BACTERIA VACCINE VECTOR
ATE546153T1 (de) Kombinationen von tumor-assoziierten antigenen zur behandlung von verschiedenen krebstypen
DE60136563D1 (de) Salmonella vakzine
EA200702254A1 (ru) Вакцинная композиция, содержащая в-субъединицу термолабильного токсина e.coli и антиген и адъювант
ATE518012T1 (de) Isolate des das reproduktions- und atemwegssyndrom verursachenden schweinevirus und ihre verwendung
ATE417856T1 (de) Motilidverbindungen
ZA200000370B (en) Novel antigenic class of avian reoviruses.
CY1109496T1 (el) Τρυγικο και φωσφορικο αλας της 3,4-διαμινοπυριδινης, φαρμακευτικες συνθεσεις και χρησεις αυτων
ATE380557T1 (de) E. coli vakzin zur protektion von geflügel gegen colibazillose
SG147465A1 (en) Vaccine
ATE435028T1 (de) Impfstoff gegen neisseria infektion
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
GB0317733D0 (en) Organic compounds
GB0409559D0 (en) Polypeptide
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1112747

Country of ref document: EP